Abbott (ABT) to Reduce Childhood Malnutrition With New Pact
https://www.zacks.com/stock/news/2237550/abbott-abt-to-reduce-childhood-malnutrition-with-new-pact?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2237550
Mar 07, 2024 - Abbott's (ABT) latest partnership supports its sustainability goal of transforming care for malnutrition and improving the lives of 3 billion people per year by the decade's end.
0
Phibro (PAHC) Appears Well Poised on Launches, Vaccine Sales
https://www.zacks.com/stock/news/2237419/phibro-pahc-appears-well-poised-on-launches-vaccine-sales?cid=CS-ZC-FT-analyst_blog|zer_report_update-2237419
Mar 07, 2024 - Phibro (PAHC) is focusing on new developments along with incremental registrations and growing volumes of existing nutritional specialties and vaccine technologies.
0
Reasons to Retain Inari Medical (NARI) in Your Portfolio Now
https://www.zacks.com/stock/news/2237411/reasons-to-retain-inari-medical-nari-in-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2237411
Mar 07, 2024 - Inari Medical (NARI) continues to benefit from its commitment to understanding the venous system. However, its dependency on the adoption of products is a concern.
0
QuidelOrtho's (QDEL) New Approval to Aid Pre-eclampsia Diagnosis
https://www.zacks.com/stock/news/2237410/quidelortho-s-qdel-new-approval-to-aid-pre-eclampsia-diagnosis?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2237410
Mar 07, 2024 - QuidelOrtho's (QDEL) receipt of Health Canada's approval is likely to aid in the diagnosis of preterm pre-eclampsia and prognosis of delivery in symptomatic women.
0
Here's Why You Should Retain Merit Medical (MMSI) Stock for Now
https://www.zacks.com/stock/news/2237409/here-s-why-you-should-retain-merit-medical-mmsi-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2237409
Mar 07, 2024 - Merit Medical's (MMSI) strong product portfolio raises optimism about the stock.
0
DaVita (DVA) Expands Operational Footprint Via New Agreement
https://www.zacks.com/stock/news/2236716/davita-dva-expands-operational-footprint-via-new-agreement?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2236716
Mar 06, 2024 - DaVita's (DVA) latest agreement is expected to serve a wider patient pool across Latin America.
0
Are Investors Undervaluing Cardinal Health (CAH) Right Now?
https://www.zacks.com/stock/news/2236660/are-investors-undervaluing-cardinal-health-cah-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_2-2236660
Mar 06, 2024 - Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
0
3 Top-Ranked Stocks to Buy for Stability
https://www.zacks.com/commentary/2236265/3-top-ranked-stocks-to-buy-for-stability?cid=CS-ZC-FT-investment_ideas-2236265
Mar 05, 2024 - Targeting low-beta stocks can provide a valuable layer of stability for portfolios. After all, defense wins ballgames.
0
Reasons to Retain Prestige Consumer (PBH) Stock for Now
https://www.zacks.com/stock/news/2236222/reasons-to-retain-prestige-consumer-pbh-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2236222
Mar 05, 2024 - Investors are optimistic about Prestige Consumer (PBH) on increasing gain in market share for its wide array of brands.
0
CVS Health (CVS) Expands In-Home Diagnostic Care With New Test
https://www.zacks.com/stock/news/2236218/cvs-health-cvs-expands-in-home-diagnostic-care-with-new-test?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2236218
Mar 05, 2024 - CVS Health's (CVS) new launch will enable early detection of heart arrhythmia and can help mitigate symptoms and more severe complications.
0